zraviv06 | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

About:

Website
Details

Posts by :

June 2, 2013 Akt inhibition for cancer treatment, where do we stand today?
June 1, 2013 FDA approved two drugs and a companion diagnostic test for the treatment of advanced or unresectable cutaneous melanoma patients
May 22, 2013 Soft Tissue Sarcoma: an Overview
May 9, 2013 The Development of siRNA-Based Therapies for Cancer
April 23, 2013 Whole exome somatic mutations analysis of malignant melanoma contributes to the development of personalized cancer therapy for this disease
April 6, 2013 Targeting Mitochondrial-bound Hexokinase for Cancer Therapy
March 25, 2013 Cancer Screening at Sourasky Medical Center Cancer Prevention Center in Tel-Aviv
March 16, 2013 A P(hD)aradox
March 7, 2013 The Importance of Cancer Prevention Programs: New Percpectives for Fighting Cancer

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 1,254 other subscribers
Recent Posts
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
- Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
- Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
- Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
- Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
- Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
- The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
- Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
- Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation October 4, 2022
Archives
Archives
Categories
Categories
Meta